Morphine potentiates HIV-1 gp120-induced neuronal apoptosis

Journal of Infectious Diseases

Volumn 191, Issue 6, 2005, Pages 886-889

  Hu, Shuxian ^a,b   Sheng, Wen S ^a,b   Lokensgard, James R ^a,b   Peterson, Phillip K ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVATION; FETUS; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROGLIA; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL CULTURE; NEUROTOXICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CELLS, CULTURED; DRUG SYNERGISM; FETUS; HIV ENVELOPE PROTEIN GP120; HUMANS; MORPHINE; NARCOTICS; NEUROGLIA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 14844293853     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427830     Document Type: Article

References (15)

1. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998; 83:36-44.
2. Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16:209-19.
3. Wang F, So Y, Vittinghoff E, et al. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:75-82.
4. Davies J, Everall IP, Weich S, McLaughlin J, Scaravilli F, Lantos PL. HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS 1997; 11:1145-50.
5. Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology 1998; 50:1814-20.
6. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: effect of neocortical involvement. Brain 1998; 121:2043-52.
7. Tomlinson GS, Simmonds P, Busuttil A, Chiswick A, Bell JE. Upregulation of microglia in drug users with and without pre-symptomatic HIV infection. Neuropathol Appl Neurobiol 1999; 25:369-79.
8. Nath A, Hauser KF, Wojna V, et al. Molecular basis for interactions of HlV and drugs of abuse. J Acquir Immune Defic Syndr 2002; 31(Suppl 2):S62-9.
9. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-94.
10. Anderson E, Zink W, Xiong H, Gendelman HE. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 2002; 31(Suppl 2):S43-54.
11. Williams KC, Hickey WR. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002; 25:537-62.
12. Gurwell JA, Nath A, Sun Q, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001; 102:555-63.
13. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002; 42:829-36.
14. Chao CC, Hu S, Shark KB, Sheng WS, Gekker G, Peterson PK. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther 1997; 281:998-1004.
15. Singhal PC, Bhaskaran M, Patel J, et al. Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 2002; 168:4025-33.